Imatinib Mesylate Tablet IP

Key Benefits
- Used in the treatment of chronic myeloid leukaemia (CML)
- Used for certain cases of acute lymphocytic leukaemia (ALL)
- Helps manage gastrointestinal stromal tumours (GIST)
- Blocks abnormal tyrosine kinase activity
- Helps inhibit the growth and multiplication of cancer cells
- Supports targeted management of cancers driven by specific abnormal proteins
How It Works
Imatinib Mesylate blocks the activity of specific tyrosine kinase proteins, including BCR-ABL. These abnormal proteins can send signals that promote uncontrolled cancer-cell growth. By inhibiting their activity, Imatinib helps slow the proliferation of cancer cells and can promote programmed cell death (apoptosis) in certain abnormal cells.
How to Use
- Take Imatinib Mesylate exactly as prescribed by your doctor.
- It is generally taken with food and a large glass of water to reduce stomach irritation.
- Take the medicine at the same time each day as recommended.
- Swallow the tablet whole unless your doctor provides different instructions.
- Do not change the dose or stop treatment without medical advice.
- Regular blood tests and medical monitoring may be required during treatment.
Important Information
Imatinib Mesylate should be used under the supervision of an oncologist or qualified healthcare professional. Common side effects may include nausea, vomiting, diarrhea, muscle cramps, fatigue, headache, rash, and fluid retention. Regular blood tests may be required to monitor blood counts and liver function. Inform your doctor about other medicines, medical conditions, pregnancy, or plans to become pregnant before starting treatment.